HIV-1 pathways

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (33)

hsa:388372 CCL4L2, AT744.2, CCL4L, SCYA4L; chemokine (C-C motif) ligand 4-like 2; K12964 C-C motif chemokine 4 hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5 hsa:10803 CCR9, CDw199, GPR-9-6, GPR28; chemokine (C-C motif) receptor 9; K04184 C-C chemokine receptor type 9 hsa:58191 CXCL16, CXCLG16, SR-PSOX, SRPSOX; chemokine (C-X-C motif) ligand 16; K10035 C-X-C motif chemokine 16 hsa:6374 CXCL5, ENA-78, SCYB5; chemokine (C-X-C motif) ligand 5; K05506 C-X-C motif chemokine 5/6 hsa:4283 CXCL9, CMK, Humig, MIG, SCYB9, crg-10; chemokine (C-X-C motif) ligand 9; K05416 C-X-C motif chemokine 9 hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4 hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:2056 EPO, EP, MGC138142, MVCD2; erythropoietin; K05437 erythropoietin hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:56832 IFNK, RP11-27J8.1; interferon, kappa; K05441 interferon, kappa hsa:3588 IL10RB, CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2; interleukin 10 receptor, beta; K05135 interleukin 10 receptor beta hsa:3597 IL13RA1, CD213A1, IL-13Ra, NR4; interleukin 13 receptor, alpha 1; K05076 interleukin 13 receptor alpha-1 hsa:8807 IL18RAP, ACPL, CD218b, CDw218b, IL18RB, MGC120589, MGC120590; interleukin 18 receptor accessory protein; K05174 interleukin 18 receptor accessory protein hsa:29949 IL19, IL-10C, MDA1, NG.1, ZMDA1; interleukin 19; K05444 interleukin 19/20/24 hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I hsa:50615 IL21R, MGC10967, NILR; interleukin 21 receptor; K05075 interleukin 21 receptor hsa:58985 IL22RA1, CRF2-9, IL22R, IL22R1; interleukin 22 receptor, alpha 1; K05138 interleukin 22 receptor alpha 1 hsa:64806 IL25, IL17E; interleukin 25; K05493 interleukin 17E hsa:282616 IL28A, IFNL2, IL-28A; interleukin 28A (interferon, lambda 2); K05447 interleukin 28/29 (interferon, lambda) hsa:163702 IL28RA, CRF2/12, IFNLR, IFNLR1, IL-28R1, LICR2; interleukin 28 receptor, alpha (interferon, lambda receptor); K05140 interleukin 28 receptor alpha hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor hsa:4352 MPL, C-MPL, CD110, MPLV, TPOR; myeloproliferative leukemia virus oncogene; K05082 thrombopoietin receptor hsa:5473 PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7); K10029 platelet basic protein hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:8793 TNFRSF10D, CD264, DCR2, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10 hsa:3604 TNFRSF9, 4-1BB, CD137, CDw137, ILA, MGC2172; tumor necrosis factor receptor superfamily, member 9; K05146 tumor necrosis factor receptor superfamily member 9 hsa:8600 TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf; tumor necrosis factor (ligand) superfamily, member 11; K05473 tumor necrosis factor (ligand) superfamily, member 11 hsa:8741 TNFSF13, APRIL, CD256, FLJ57090, TALL-2, TALL2, TRDL-1, ZTNF2; tumor necrosis factor (ligand) superfamily, member 13; K05475 tumor necrosis factor (ligand) superfamily, member 13 hsa:8740 TNFSF14, CD258, HVEML, LIGHT, LTg, TR2; tumor necrosis factor (ligand) superfamily, member 14; K05477 tumor necrosis factor (ligand) superfamily, member 14 hsa:7292 TNFSF4, CD134L, CD252, GP34, OX-40L, OX4OL, TXGP1; tumor necrosis factor (ligand) superfamily, member 4; K05469 tumor necrosis factor (ligand) superfamily, member 4

hsa04380 Osteoclast differentiation - Homo sapiens (human) (27)

hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1540 CYLD, CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, KIAA0849, MFT, MFT1, SBS, TEM, USPL2; cylindromatosis (turban tumor syndrome) (EC:3.4.19.12); K08601 ubiquitin thioesterase CYLD [EC:3.1.2.15] hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b hsa:9103 FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:10859 LILRB1, CD85, CD85J, FLJ37515, ILT2, LIR-1, LIR1, MIR-7, MIR7; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1; K06512 leukocyte immunoglobulin-like receptor hsa:10288 LILRB2, CD85D, ILT4, LILRA6, LIR-2, LIR2, MIR-10, MIR10; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; K06512 leukocyte immunoglobulin-like receptor hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:126014 OSCAR, MGC33613, PIGR3; osteoclast associated, immunoglobulin-like receptor; K14377 osteoclast-associated immunoglobulin-like receptor hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:55423 SIRPG, CD172g, FLJ42230, SIRP-B2, SIRPB2, SIRPgamma, bA77C3.1; signal-regulatory protein gamma; K06551 signal-regulatory protein hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:8600 TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf; tumor necrosis factor (ligand) superfamily, member 11; K05473 tumor necrosis factor (ligand) superfamily, member 11 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6 hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (26)

hsa:716 C1S, FLJ44757; complement component 1, s subcomponent (EC:3.4.21.42); K01331 complement component 1, s subcomponent [EC:3.4.21.42] hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3 hsa:720 C4A, C4, C4A2, C4A3, C4A4, C4A6, C4S, CO4, CPAMD2, MGC164979, RG; complement component 4A (Rodgers blood group); K03989 complement component 4 hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4 hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5 hsa:729 C6; complement component 6; K03995 complement component 6 hsa:730 C7; complement component 7; K03996 complement component 7 hsa:731 C8A; complement component 8, alpha polypeptide; K03997 complement component 8 subunit alpha hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b hsa:9103 FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:6628 SNRPB, COD, SNRPB1, Sm-B/B', SmB/B', SmB/SmB', snRNP-B; small nuclear ribonucleoprotein polypeptides B and B1; K11086 small nuclear ribonucleoprotein B and B' hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:6737 TRIM21, RNF81, RO52, SSA, SSA1; tripartite motif-containing 21; K10651 tripartite motif-containing protein 21 hsa:6738 TROVE2, RO60, RORNP, SSA2; TROVE domain family, member 2; K11089 60 kDa SS-A/Ro ribonucleoprotein

hsa04145 Phagosome - Homo sapiens (human) (26)

hsa:537 ATP6AP1, 16A, ATP6IP1, ATP6S1, Ac45, CF2, MGC129781, VATPS1, XAP-3, XAP3; ATPase, H+ transporting, lysosomal accessory protein 1 (EC:3.6.3.14); K03662 V-type H+-transporting ATPase S1 subunit [EC:3.6.3.14] hsa:23545 ATP6V0A2, A2, ARCL, ATP6A2, ATP6N1D, J6B7, RTF, STV1, TJ6, TJ6M, TJ6S, VPH1, WSS; ATPase, H+ transporting, lysosomal V0 subunit a2 (EC:3.6.3.6); K02154 V-type H+-transporting ATPase subunit I [EC:3.6.3.14] hsa:527 ATP6V0C, ATP6C, ATP6L, ATPL, VATL, VPPC, Vma3; ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (EC:3.6.3.14); K02155 V-type H+-transporting ATPase 16kDa proteolipid subunit [EC:3.6.3.14] hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3 hsa:64581 CLEC7A, BGR, CANDF4, CLECSF12, DECTIN1; C-type lectin domain family 7, member A; K10074 C-type lectin domain family 7, member A hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b hsa:9103 FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:10312 TCIRG1, ATP6N1C, ATP6V0A3, Atp6i, OC-116kDa, OC116, OPTB1, Stv1, TIRC7, Vph1, a3; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (EC:3.6.3.6); K02154 V-type H+-transporting ATPase subunit I [EC:3.6.3.14] hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (25)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:3002 GZMB, CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (EC:3.4.21.79); K01353 granzyme B [EC:3.4.21.79] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1 hsa:3384 ICAM2, CD102; intercellular adhesion molecule 2; K06523 intercellular adhesion molecule 2 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:100507436 MICA, FLJ36918, FLJ60820, MGC111087, MGC21250, PERB11.1; MHC class I polypeptide-related sequence A hsa:4277 MICB, PERB11.2; MHC class I polypeptide-related sequence B; K07985 MHC class I-related protein hsa:10725 NFAT5, KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP; nuclear factor of activated T-cells 5, tonicity-responsive; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1 hsa:135250 RAET1E, LETAL, MGC125308, MGC125309, RAET1E2, ULBP4, bA350J20.7; retinoic acid early transcript 1E; K07987 retinoic acid early transcript 1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:8793 TNFRSF10D, CD264, DCR2, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10 hsa:80329 ULBP1, RAET1I; UL16 binding protein 1; K07986 UL16 binding protein

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (24)

hsa:57863 CADM3, BIgR, FLJ10698, IGSF4B, NECL1, Necl-1, TSLL1, synCAM3; cell adhesion molecule 3; K06780 immunoglobulin superfamily, member 4B hsa:933 CD22, FLJ22814, MGC130020, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide hsa:1001 CDH3, CDHP, HJMD, PCAD; cadherin 3, type 1, P-cadherin (placental); K06796 cadherin 3, type 1, P-cadherin hsa:6900 CNTN2, AXT, DKFZp781D102, FLJ42746, MGC157722, TAG-1, TAX, TAX1; contactin 2 (axonal); K06760 contactin 2 hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1 hsa:3384 ICAM2, CD102; intercellular adhesion molecule 2; K06523 intercellular adhesion molecule 2 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:8174 MADCAM1, MACAM1; mucosal vascular addressin cell adhesion molecule 1; K06779 mucosal vascular addressin cell adhesion molecule 1 hsa:6693 SPN, CD43, GPL115, LSN; sialophorin; K06477 sialophorin

hsa05145 Toxoplasmosis - Homo sapiens (human) (23)

hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5 hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8 hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3588 IL10RB, CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2; interleukin 10 receptor, beta; K05135 interleukin 10 receptor beta hsa:3717 JAK2, JTK10; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor hsa:23643 LY96, ESOP-1, MD-2, MD2, ly-96; lymphocyte antigen 96; K05400 lymphocyte antigen 96 hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6 hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa01100 Metabolic pathways - Homo sapiens (human) (23)

hsa:132 ADK, AK; adenosine kinase (EC:2.7.1.20); K00856 adenosine kinase [EC:2.7.1.20] hsa:10554 AGPAT1, 1-AGPAT1, G15, LPAAT-alpha, LPAATA, MGC4007, MGC5423; 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (EC:2.3.1.51); K13509 lysophosphatidate acyltransferase [EC:2.3.1.51] hsa:79053 ALG8, CDG1H, MGC2840; asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae); K03849 alpha-1,3-glucosyltransferase [EC:2.4.1.-] hsa:8639 AOC3, HPAO, SSAO, VAP-1, VAP1; amine oxidase, copper containing 3 (vascular adhesion protein 1) (EC:1.4.3.21); K00276 primary-amine oxidase [EC:1.4.3.21] hsa:537 ATP6AP1, 16A, ATP6IP1, ATP6S1, Ac45, CF2, MGC129781, VATPS1, XAP-3, XAP3; ATPase, H+ transporting, lysosomal accessory protein 1 (EC:3.6.3.14); K03662 V-type H+-transporting ATPase S1 subunit [EC:3.6.3.14] hsa:23545 ATP6V0A2, A2, ARCL, ATP6A2, ATP6N1D, J6B7, RTF, STV1, TJ6, TJ6M, TJ6S, VPH1, WSS; ATPase, H+ transporting, lysosomal V0 subunit a2 (EC:3.6.3.6); K02154 V-type H+-transporting ATPase subunit I [EC:3.6.3.14] hsa:527 ATP6V0C, ATP6C, ATP6L, ATPL, VATL, VPPC, Vma3; ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (EC:3.6.3.14); K02155 V-type H+-transporting ATPase 16kDa proteolipid subunit [EC:3.6.3.14] hsa:10331 B3GNT3, B3GAL-T8, B3GN-T3, B3GNT-3, HP10328, TMEM3, beta3Gn-T3; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3; K07970 beta-1,3-N-acetylglucosaminyltransferase 3 [EC:2.4.1.-] hsa:683 BST1, CD157; bone marrow stromal cell antigen 1 (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:2595 GANC, MGC138256; glucosidase, alpha; neutral C (EC:3.2.1.20); K12317 neutral alpha-glucosidase C [EC:3.2.1.20] hsa:2632 GBE1, GBE; glucan (1,4-alpha-), branching enzyme 1 (EC:2.4.1.18); K00700 1,4-alpha-glucan branching enzyme [EC:2.4.1.18] hsa:2720 GLB1, EBP, ELNR1; galactosidase, beta 1 (EC:3.2.1.23); K12309 beta-galactosidase [EC:3.2.1.23] hsa:3067 HDC, MGC163399; histidine decarboxylase (EC:4.1.1.22); K01590 histidine decarboxylase [EC:4.1.1.22] hsa:169355 IDO2, INDOL1; indoleamine 2,3-dioxygenase 2 (EC:1.13.11.52); K00463 indoleamine 2,3-dioxygenase [EC:1.13.11.52] hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2] hsa:3636 INPPL1, SHIP2; inositol polyphosphate phosphatase-like 1; K01106 inositol-1,4,5-trisphosphate 5-phosphatase [EC:3.1.3.56] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6] hsa:5980 REV3L, POLZ, REV3; REV3-like, catalytic subunit of DNA polymerase zeta (yeast) (EC:2.7.7.7); K02350 DNA polymerase zeta subunit [EC:2.7.7.7] hsa:10998 SLC27A5, ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2; solute carrier family 27 (fatty acid transporter), member 5 (EC:6.2.1.7); K08748 solute carrier family 27 (fatty acid transporter), member 5 [EC:6.2.1.7] hsa:10312 TCIRG1, ATP6N1C, ATP6V0A3, Atp6i, OC-116kDa, OC116, OPTB1, Stv1, TIRC7, Vph1, a3; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (EC:3.6.3.6); K02154 V-type H+-transporting ATPase subunit I [EC:3.6.3.14] hsa:7384 UQCRC1, D3S3191, QCR1, UQCR1; ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2); K00414 ubiquinol-cytochrome c reductase core subunit 1 [EC:1.10.2.2]

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (21)

hsa:933 CD22, FLJ22814, MGC130020, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen hsa:945 CD33, FLJ00391, SIGLEC-3, SIGLEC3, p67; CD33 molecule; K06473 CD33 antigen hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen hsa:921 CD5, LEU1, T1; CD5 molecule; K06455 CD5 antigen hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide hsa:1378 CR1, C3BR, C4BR, CD35, KN; complement component (3b/4b) receptor 1 (Knops blood group); K04011 complement component (3b/4b) receptor 1 hsa:1380 CR2, C3DR, CD21, SLEB9; complement component (3d/Epstein Barr virus) receptor 2; K04012 complement component (3d/Epstein Barr virus) receptor 2 hsa:2056 EPO, EP, MGC138142, MVCD2; erythropoietin; K05437 erythropoietin hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:931 MS4A1, B1, Bp35, CD20, LEU-16, MGC3969, MS4A2, S7; membrane-spanning 4-domains, subfamily A, member 1; K06466 membrane-spanning 4-domains, subfamily A, member 1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05150 Staphylococcus aureus infection - Homo sapiens (human) (20)

hsa:716 C1S, FLJ44757; complement component 1, s subcomponent (EC:3.4.21.42); K01331 complement component 1, s subcomponent [EC:3.4.21.42] hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3 hsa:720 C4A, C4, C4A2, C4A3, C4A4, C4A6, C4S, CO4, CPAMD2, MGC164979, RG; complement component 4A (Rodgers blood group); K03989 complement component 4 hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4 hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5 hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b hsa:9103 FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2359 FPR3, FML2_HUMAN, FMLPY, FPRH1, FPRH2, FPRL2, RMLP-R-I; formyl peptide receptor 3; K04173 formyl peptide receptor-like hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:5648 MASP1, CRARF, CRARF1, DKFZp686I01199, FLJ26383, MAP1, MASP, MASP3, MAp44, MGC126283, MGC126284, PRSS5, RaRF; mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (EC:3.4.21.-); K03992 mannan-binding lectin serine protease 1 [EC:3.4.21.-]

hsa05140 Leishmaniasis - Homo sapiens (human) (19)

hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3 hsa:1378 CR1, C3BR, C4BR, CD35, KN; complement component (3b/4b) receptor 1 (Knops blood group); K04011 complement component (3b/4b) receptor 1 hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:9103 FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3717 JAK2, JTK10; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (19)

hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:4283 CXCL9, CMK, Humig, MIG, SCYB9, crg-10; chemokine (C-X-C motif) ligand 9; K05416 C-X-C motif chemokine 9 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3 hsa:23643 LY96, ESOP-1, MD-2, MD2, ly-96; lymphocyte antigen 96; K05400 lymphocyte antigen 96 hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:1326 MAP3K8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT; mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25); K04415 mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25] hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7096 TLR1, CD281, DKFZp547I0610, DKFZp564I0682, KIAA0012, MGC104956, MGC126311, MGC126312, TIL, TIL._LPRS5, rsc786; toll-like receptor 1; K05398 toll-like receptor 1 hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7098 TLR3, CD283; toll-like receptor 3; K05401 toll-like recepto 3 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:51311 TLR8, CD288, MGC119599, MGC119600; toll-like receptor 8; K10170 toll-like receptor 8 hsa:54106 TLR9, CD289; toll-like receptor 9; K10161 toll-like receptor 9 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6 Added from not found TLR10

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (18)

hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:3002 GZMB, CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (EC:3.4.21.79); K01353 granzyme B [EC:3.4.21.79] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:3329 HSPD1, CPN60, GROEL, HLD4, HSP60, HSP65, HuCHA60, SPG13; heat shock 60kDa protein 1 (chaperonin); K04077 chaperonin GroEL hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (18)

hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:1154 CISH, CIS, CIS-1, G18, SOCS; cytokine inducible SH2-containing protein; K04701 cytokine inducible SH2-containing protein hsa:2056 EPO, EP, MGC138142, MVCD2; erythropoietin; K05437 erythropoietin hsa:56832 IFNK, RP11-27J8.1; interferon, kappa; K05441 interferon, kappa hsa:3588 IL10RB, CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2; interleukin 10 receptor, beta; K05135 interleukin 10 receptor beta hsa:3597 IL13RA1, CD213A1, IL-13Ra, NR4; interleukin 13 receptor, alpha 1; K05076 interleukin 13 receptor alpha-1 hsa:29949 IL19, IL-10C, MDA1, NG.1, ZMDA1; interleukin 19; K05444 interleukin 19/20/24 hsa:50615 IL21R, MGC10967, NILR; interleukin 21 receptor; K05075 interleukin 21 receptor hsa:58985 IL22RA1, CRF2-9, IL22R, IL22R1; interleukin 22 receptor, alpha 1; K05138 interleukin 22 receptor alpha 1 hsa:282616 IL28A, IFNL2, IL-28A; interleukin 28A (interferon, lambda 2); K05447 interleukin 28/29 (interferon, lambda) hsa:163702 IL28RA, CRF2/12, IFNLR, IFNLR1, IL-28R1, LICR2; interleukin 28 receptor, alpha (interferon, lambda receptor); K05140 interleukin 28 receptor alpha hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor hsa:3717 JAK2, JTK10; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] hsa:3718 JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2] hsa:4352 MPL, C-MPL, CD110, MPLV, TPOR; myeloproliferative leukemia virus oncogene; K05082 thrombopoietin receptor hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa05330 Allograft rejection - Homo sapiens (human) (17)

hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:3002 GZMB, CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (EC:3.4.21.79); K01353 granzyme B [EC:3.4.21.79] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05320 Autoimmune thyroid disease - Homo sapiens (human) (17)

hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:3002 GZMB, CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (EC:3.4.21.79); K01353 granzyme B [EC:3.4.21.79] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1 hsa:7038 TG, AITD3, TGN; thyroglobulin; K10809 thyroglobulin

hsa04010 MAPK signaling pathway - Homo sapiens (human) (17)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8 hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:1326 MAP3K8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT; mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25); K04415 mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25] hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta hsa:5924 RASGRF2, DKFZp781H1715, GRF2, RAS-GRF2; Ras protein-specific guanine nucleotide-releasing factor 2; K12326 Ras-specific guanine nucleotide-releasing factor 2 hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa04062 Chemokine signaling pathway - Homo sapiens (human) (17)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:388372 CCL4L2, AT744.2, CCL4L, SCYA4L; chemokine (C-C motif) ligand 4-like 2; K12964 C-C motif chemokine 4 hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5 hsa:10803 CCR9, CDw199, GPR-9-6, GPR28; chemokine (C-C motif) receptor 9; K04184 C-C chemokine receptor type 9 hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:58191 CXCL16, CXCLG16, SR-PSOX, SRPSOX; chemokine (C-X-C motif) ligand 16; K10035 C-X-C motif chemokine 16 hsa:6374 CXCL5, ENA-78, SCYB5; chemokine (C-X-C motif) ligand 5; K05506 C-X-C motif chemokine 5/6 hsa:4283 CXCL9, CMK, Humig, MIG, SCYB9, crg-10; chemokine (C-X-C motif) ligand 9; K05416 C-X-C motif chemokine 9 hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4 hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3717 JAK2, JTK10; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] hsa:3718 JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2] hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5473 PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7); K10029 platelet basic protein hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa05332 Graft-versus-host disease - Homo sapiens (human) (17)

hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:3002 GZMB, CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (EC:3.4.21.79); K01353 granzyme B [EC:3.4.21.79] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05416 Viral myocarditis - Homo sapiens (human) (17)

hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1

hsa04612 Antigen processing and presentation - Homo sapiens (human) (16)

hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8 hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04144 Endocytosis - Homo sapiens (human) (16)

hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5 hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4 hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8 hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8 hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor hsa:6456 SH3GL2, CNSA2, EEN-B1, FLJ20276, FLJ25015, SH3D2A, SH3P4; SH3-domain GRB2-like 2; K11247 endophilin-A hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (15)

hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:1326 MAP3K8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT; mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25); K04415 mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25] hsa:10725 NFAT5, KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP; nuclear factor of activated T-cells 5, tonicity-responsive; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 TRA@ and TRB@ are viral homologues and should be on this figure (Both are autoantigens)

Hsa05160 Hepatitis C - Homo sapiens (human) (15)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3 hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor hsa:57506 MAVS, CARDIF, DKFZp547C224, DKFZp666M015, FLJ27482, FLJ35386, FLJ38051, FLJ41962, IPS-1, IPS1, KIAA1271, MGC3260, VISA; mitochondrial antiviral signaling protein; K12648 mitochondrial antiviral-signaling protein hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:4938 OAS1, IFI-4, OIAS, OIASI; 2',5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-); K14216 2'-5'-oligoadenylate synthetase hsa:4939 OAS2, MGC78578; 2'-5'-oligoadenylate synthetase 2, 69/71kDa (EC:2.7.7.-); K14216 2'-5'-oligoadenylate synthetase hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7098 TLR3, CD283; toll-like receptor 3; K05401 toll-like recepto 3 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6 hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa04610 Complement and coagulation cascades - Homo sapiens (human) (14)

hsa:2 A2M, CPAMD5, DKFZp779B086, S863-7; alpha-2-macroglobulin; K03910 alpha-2-macroglobulin hsa:716 C1S, FLJ44757; complement component 1, s subcomponent (EC:3.4.21.42); K01331 complement component 1, s subcomponent [EC:3.4.21.42] hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3 hsa:720 C4A, C4, C4A2, C4A3, C4A4, C4A6, C4S, CO4, CPAMD2, MGC164979, RG; complement component 4A (Rodgers blood group); K03989 complement component 4 hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4 hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5 hsa:729 C6; complement component 6; K03995 complement component 6 hsa:730 C7; complement component 7; K03996 complement component 7 hsa:731 C8A; complement component 8, alpha polypeptide; K03997 complement component 8 subunit alpha hsa:1378 CR1, C3BR, C4BR, CD35, KN; complement component (3b/4b) receptor 1 (Knops blood group); K04011 complement component (3b/4b) receptor 1 hsa:1380 CR2, C3DR, CD21, SLEB9; complement component (3d/Epstein Barr virus) receptor 2; K04012 complement component (3d/Epstein Barr virus) receptor 2 hsa:2152 F3, CD142, FLJ17960, TF, TFA; coagulation factor III (thromboplastin, tissue factor); K03901 coagulation factor III (tissue factor) hsa:5648 MASP1, CRARF, CRARF1, DKFZp686I01199, FLJ26383, MAP1, MASP, MASP3, MAp44, MGC126283, MGC126284, PRSS5, RaRF; mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (EC:3.4.21.-); K03992 mannan-binding lectin serine protease 1 [EC:3.4.21.-] hsa:5265 SERPINA1, A1A, A1AT, AAT, MGC23330, MGC9222, PI, PI1, PRO2275, alpha1AT; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; K03984 alpha-1-antitrypsin

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (14)

hsa:843 CASP10, ALPS2, FLICE2, MCH4; caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63); K04400 caspase 10 [EC:3.4.22.63] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1540 CYLD, CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, KIAA0849, MFT, MFT1, SBS, TEM, USPL2; cylindromatosis (turban tumor syndrome) (EC:3.4.19.12); K08601 ubiquitin thioesterase CYLD [EC:3.1.2.15] hsa:64135 IFIH1, Hlcd, IDDM19, MDA-5, MDA5, MGC133047; interferon induced with helicase C domain 1 (EC:3.6.4.13); K12647 interferon-induced helicase C domain-containing protein 1 [EC:3.6.1.-] hsa:56832 IFNK, RP11-27J8.1; interferon, kappa; K05441 interferon, kappa hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3 hsa:57506 MAVS, CARDIF, DKFZp547C224, DKFZp666M015, FLJ27482, FLJ35386, FLJ38051, FLJ41962, IPS-1, IPS1, KIAA1271, MGC3260, VISA; mitochondrial antiviral signaling protein; K12648 mitochondrial antiviral-signaling protein hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:79671 NLRX1, CLR11.3, DLNB26, FLJ21478, MGC131937, MGC21025, NOD26, NOD5, NOD9; NLR family member X1; K12653 NLR family member X1 hsa:340061 TMEM173, ERIS, FLJ38577, MITA, MPYS, NET23, STING; transmembrane protein 173; K12654 transmembrane protein 173 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6 hsa:7706 TRIM25, EFP, RNF147, Z147, ZNF147; tripartite motif-containing 25 (EC:6.3.2.19); K10652 tripartite motif-containing protein 25

hsa04672 Intestinal immune network for IgA production - Homo sapiens (human) (13)

hsa:10803 CCR9, CDw199, GPR-9-6, GPR28; chemokine (C-C motif) receptor 9; K04184 C-C chemokine receptor type 9 hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4 hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:8174 MADCAM1, MACAM1; mucosal vascular addressin cell adhesion molecule 1; K06779 mucosal vascular addressin cell adhesion molecule 1 hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:8741 TNFSF13, APRIL, CD256, FLJ57090, TALL-2, TALL2, TRDL-1, ZTNF2; tumor necrosis factor (ligand) superfamily, member 13; K05475 tumor necrosis factor (ligand) superfamily, member 13

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (12)

hsa:933 CD22, FLJ22814, MGC130020, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1380 CR2, C3DR, CD21, SLEB9; complement component (3d/Epstein Barr virus) receptor 2; K04012 complement component (3d/Epstein Barr virus) receptor 2 hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3635 INPP5D, MGC104855, MGC142140, MGC142142, SHIP, SHIP1, SIP-145, hp51CN; inositol polyphosphate-5-phosphatase, 145kDa; K03084 inositol polyphosphate-5-phosphatase hsa:10725 NFAT5, KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP; nuclear factor of activated T-cells 5, tonicity-responsive; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa05142 Chagas disease - Homo sapiens (human) (12)

hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3 hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:54106 TLR9, CD289; toll-like receptor 9; K10161 toll-like receptor 9 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (11)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:55740 ENAH, ENA, MENA, NDPP1; enabled homolog (Drosophila); K05746 enabled hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:3687 ITGAX, CD11C, SLEB6; integrin, alpha X (complement component 3 receptor 4 subunit); K06462 integrin alpha X hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4 hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa04623 Cytosolic DNA-sensing pathway - Homo sapiens (human) (11)

hsa:388372 CCL4L2, AT744.2, CCL4L, SCYA4L; chemokine (C-C motif) ligand 4-like 2; K12964 C-C motif chemokine 4 hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3 hsa:57506 MAVS, CARDIF, DKFZp547C224, DKFZp666M015, FLJ27482, FLJ35386, FLJ38051, FLJ41962, IPS-1, IPS1, KIAA1271, MGC3260, VISA; mitochondrial antiviral signaling protein; K12648 mitochondrial antiviral-signaling protein hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6] hsa:11035 RIPK3, RIP3; receptor-interacting serine-threonine kinase 3 (EC:2.7.11.1); K08847 receptor-interacting serine/threonine-protein kinase 3 [EC:2.7.11.1] hsa:340061 TMEM173, ERIS, FLJ38577, MITA, MPYS, NET23, STING; transmembrane protein 173; K12654 transmembrane protein 173 hsa:11277 TREX1, AGS1, CRV, DKFZp434J0310, DRN3, HERNS; three prime repair exonuclease 1 (EC:3.1.11.2); K10790 three prime repair exonuclease 1 [EC:3.1.11.2] hsa:81030 ZBP1, C20orf183, DAI, DLM-1, DLM1; Z-DNA binding protein 1; K12965 Z-DNA binding protein 1

hsa04210 Apoptosis - Homo sapiens (human) (11)

hsa:843 CASP10, ALPS2, FLICE2, MCH4; caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63); K04400 caspase 10 [EC:3.4.22.63] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I hsa:11213 IRAK3, ASRT5, FLJ13601, IRAKM; interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1); K04732 interleukin-1 receptor-associated kinase 3 [EC:2.7.11.1] hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:8793 TNFRSF10D, CD264, DCR2, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10

hsa05200 Pathways in cancer - Homo sapiens (human) (11)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (10)

hsa:1269 CNR2, CB2, CX5; cannabinoid receptor 2 (macrophage); K04278 cannabinoid receptor 2 (macrophage) hsa:1394 CRHR1, CRF-R, CRF1, CRFR1, CRH-R1h, CRHR, CRHR1L, CRHR1f; corticotropin releasing hormone receptor 1; K04578 corticotropin releasing hormone receptor 1 hsa:1395 CRHR2, CRFR2; corticotropin releasing hormone receptor 2; K04579 corticotropin releasing hormone receptor 2 hsa:2359 FPR3, FML2_HUMAN, FMLPY, FPRH1, FPRH2, FPRL2, RMLP-R-I; formyl peptide receptor 3; K04173 formyl peptide receptor-like hsa:2488 FSHB; follicle stimulating hormone, beta polypeptide; K05250 follicle stimulating hormone hsa:9568 GABBR2, FLJ36928, GABABR2, GPR51, GPRC3B, HG20, HRIHFB2099; gamma-aminobutyric acid (GABA) B receptor, 2; K04616 gamma-aminobutyric acid (GABA) B receptor 2 hsa:4988 OPRM1, KIAA0403, LMOR, MOR, MOR1, OPRM; opioid receptor, mu 1; K04215 opioid receptor mu 1 hsa:53829 P2RY13, GPCR1, GPR86, GPR94, P2Y13, SP174; purinergic receptor P2Y, G-protein coupled, 13; K08388 purinergic receptor P2Y, G protein-coupled, 13 hsa:9934 P2RY14, GPR105, KIAA0001, P2Y14; purinergic receptor P2Y, G-protein coupled, 14; K04299 purinergic receptor P2Y, G protein-coupled, 14 hsa:5734 PTGER4, EP4, EP4R, MGC126583; prostaglandin E receptor 4 (subtype EP4); K04261 prostaglandin E receptor 4

hsa04360 Axon guidance - Homo sapiens (human) (10)

hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4 hsa:1945 EFNA4, EFL4, EPLG4, LERK4, MGC125826; ephrin-A4; K05462 ephrin-A hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:10725 NFAT5, KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP; nuclear factor of activated T-cells 5, tonicity-responsive; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:5361 PLXNA1, DKFZp761P19121, NOV, NOVP, PLEXIN-A1, PLXN1; plexin A1; K06820 plexin A hsa:10509 SEMA4B, KIAA1745, MGC131831, SEMAC, SemC; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; K06521 semaphorin 4 hsa:8482 SEMA7A, CD108, CDw108, H-SEMA-K1, H-Sema-L, JMH, MGC126692, MGC126696, SEMAK1, SEMAL; semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group); K06529 semaphorin 7 hsa:219699 UNC5B, UNC5H2, p53RDL1; unc-5 homolog B (C. elegans); K07521 netrin receptor unc-5

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (10)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:11213 IRAK3, ASRT5, FLJ13601, IRAKM; interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1); K04732 interleukin-1 receptor-associated kinase 3 [EC:2.7.11.1] hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:8767 RIPK2, CARD3, CARDIAK, CCK, GIG30, RICK, RIP2; receptor-interacting serine-threonine kinase 2 (EC:2.7.11.1); K08846 receptor-interacting serine/threonine-protein kinase 2 [EC:2.7.11.1] hsa:10019 SH2B3, IDDM20, LNK; SH2B adaptor protein 3; K12459 SH2B adaptor protein 1/3 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa05144 Malaria - Homo sapiens (human) (9)

hsa:1378 CR1, C3BR, C4BR, CD35, KN; complement component (3b/4b) receptor 1 (Knops blood group); K04011 complement component (3b/4b) receptor 1 hsa:3039 HBA1, CD31, MGC126895, MGC126897; hemoglobin, alpha 1; K13822 hemoglobin subunit alpha hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:54106 TLR9, CD289; toll-like receptor 9; K10161 toll-like receptor 9 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (9)

hsa04666 Fc gamma R-mediated phagocytosis - Homo sapiens (human) (9)

hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b hsa:9103 FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); K06472 low affinity immunoglobulin gamma Fc region receptor II-a hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III hsa:3635 INPP5D, MGC104855, MGC142140, MGC142142, SHIP, SHIP1, SIP-145, hp51CN; inositol polyphosphate-5-phosphatase, 145kDa; K03084 inositol polyphosphate-5-phosphatase hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa04510 Focal adhesion - Homo sapiens (human) (9)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4 hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:83660 TLN2, DKFZp451B1011, DKFZp686I0976, DKFZp686K0979, ILWEQ, KIAA0320; talin 2; K06271 talin

hsa04142 Lysosome - Homo sapiens (human) (8)

hsa05131 Shigellosis - Homo sapiens (human) (8)

hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1 hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:8767 RIPK2, CARD3, CARDIAK, CCK, GIG30, RICK, RIP2; receptor-interacting serine-threonine kinase 2 (EC:2.7.11.1); K08846 receptor-interacting serine/threonine-protein kinase 2 [EC:2.7.11.1] hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (8)

hsa:64170 CARD9, CANDF2, hCARD9; caspase recruitment domain family, member 9; K12794 caspase recruitment domain-containing protein 9 hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:114548 NLRP3, AGTAVPRL, AII, AII/AVP, AVP, C1orf7, CIAS1, CLR1.1, FCAS, FCU, FLJ95925, MWS, NALP3, PYPAF1; NLR family, pyrin domain containing 3; K12800 NACHT, LRR and PYD domains-containing protein 3 hsa:8767 RIPK2, CARD3, CARDIAK, CCK, GIG30, RICK, RIP2; receptor-interacting serine-threonine kinase 2 (EC:2.7.11.1); K08846 receptor-interacting serine/threonine-protein kinase 2 [EC:2.7.11.1] hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa05146 Amoebiasis - Homo sapiens (human) (8)

hsa:731 C8A; complement component 8, alpha polypeptide; K03997 complement component 8 subunit alpha hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5272 SERPINB9, CAP-3, CAP3, PI9; serpin peptidase inhibitor, clade B (ovalbumin), member 9; K13963 serpin B hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7097 TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04012 ErbB signaling pathway - Homo sapiens (human) (7)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:9542 NRG2, DON1, HRG2, NTAK; neuregulin 2; K05456 neuregulin 2 hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (7)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04370 VEGF signaling pathway - Homo sapiens (human) (6)

hsa:10725 NFAT5, KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP; nuclear factor of activated T-cells 5, tonicity-responsive; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:9047 SH2D2A, F2771, SCAP, TSAD, VRAP; SH2 domain containing 2A; K08273 SH2 domain protein 2A

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (6)

hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:3635 INPP5D, MGC104855, MGC142140, MGC142142, SHIP, SHIP1, SIP-145, hp51CN; inositol polyphosphate-5-phosphatase, 145kDa; K03084 inositol polyphosphate-5-phosphatase hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11] hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04910 Insulin signaling pathway - Homo sapiens (human) (6)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:10211 FLOT1; flotillin 1; K07192 flotillin hsa:2319 FLOT2, ECS-1, ECS1, ESA, ESA1, M17S1; flotillin 2; K07192 flotillin hsa:3635 INPP5D, MGC104855, MGC142140, MGC142142, SHIP, SHIP1, SIP-145, hp51CN; inositol polyphosphate-5-phosphatase, 145kDa; K03084 inositol polyphosphate-5-phosphatase hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa05310 Asthma - Homo sapiens (human) (6)

hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05215 Prostate cancer - Homo sapiens (human) (6)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (6)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4 hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (6)

hsa03040 Spliceosome - Homo sapiens (human) (6)

hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8 hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8 hsa:494115 RBMXL1, DKFZp547N1117, DKFZp667D0223, FLJ32614, RBM1; RNA binding motif protein, X-linked-like 1; K12885 heterogeneous nuclear ribonucleoprotein G hsa:6625 SNRNP70, RNPU1Z, RPU1, SNRP70, Snp1, U1-70K, U170K, U1AP, U1RNP; small nuclear ribonucleoprotein 70kDa (U1); K11093 U1 small nuclear ribonucleoprotein 70kDa hsa:6628 SNRPB, COD, SNRPB1, Sm-B/B', SmB/B', SmB/SmB', snRNP-B; small nuclear ribonucleoprotein polypeptides B and B1; K11086 small nuclear ribonucleoprotein B and B' hsa:6432 SRSF7, 9G8, AAG3, SFRS7; serine/arginine-rich splicing factor 7; K12896 splicing factor, arginine/serine-rich 7

hsa05212 Pancreatic cancer - Homo sapiens (human) (6)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04020 Calcium signaling pathway - Homo sapiens (human) (6)

hsa:683 BST1, CD157; bone marrow stromal cell antigen 1 (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa05110 Vibrio cholerae infection - Homo sapiens (human) (5)

hsa04350 TGF-beta signaling pathway - Homo sapiens (human) (5)

hsa:1874 E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 E2F transcription factor 4/5 hsa:151449 GDF7, BMP12; growth differentiation factor 7; K04664 growth differentiation factor 5/6/7 hsa:4086 SMAD1, BSP1, JV4-1, JV41, MADH1, MADR1; SMAD family member 1; K04676 SMAD, mothers against DPP 1/5/8 hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00230 Purine metabolism - Homo sapiens (human) (5)

hsa:132 ADK, AK; adenosine kinase (EC:2.7.1.20); K00856 adenosine kinase [EC:2.7.1.20] hsa:4881 NPR1, ANPRA, ANPa, GUC2A, GUCY2A, NPRA; natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) (EC:4.6.1.2); K12323 atrial natriuretic peptide receptor A [EC:4.6.1.2] hsa:5143 PDE4C, DPDE1, MGC126222; phosphodiesterase 4C, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17] hsa:5150 PDE7A, HCP1, PDE7; phosphodiesterase 7A (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17] hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (5)

hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4 hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1 hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa05340 Primary immunodeficiency - Homo sapiens (human) (5)

hsa05222 Small cell lung cancer - Homo sapiens (human) (5)

hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa05100 Bacterial invasion of epithelial cells - Homo sapiens (human) (5)

hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1 hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa05020 Prion diseases - Homo sapiens (human) (5)

hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5 hsa:729 C6; complement component 6; K03995 complement component 6 hsa:730 C7; complement component 7; K03996 complement component 7 hsa:731 C8A; complement component 8, alpha polypeptide; K03997 complement component 8 subunit alpha hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (5)

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (5)

hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:3717 JAK2, JTK10; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04912 GnRH signaling pathway - Homo sapiens (human) (4)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:2488 FSHB; follicle stimulating hormone, beta polypeptide; K05250 follicle stimulating hormone hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]

hsa05221 Acute myeloid leukemia - Homo sapiens (human) (4)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10] hsa:8517 IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase gamma subunit hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (4)

hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:23643 LY96, ESOP-1, MD-2, MD2, ly-96; lymphocyte antigen 96; K05400 lymphocyte antigen 96 hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4 hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (4)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa04740 Olfactory transduction - Homo sapiens (human) (4)

hsa:1179 CLCA1, CACC, CACC1, CLCRG1, CaCC-1, FLJ95147, GOB5, hCLCA1, hCaCC-1; chloride channel accessory 1; K05027 calcium-activated chloride channel family member 1 hsa:79290 OR13A1, FLJ16797; olfactory receptor, family 13, subfamily A, member 1; K04257 olfactory receptor hsa:26686 OR4E2, OR14-42; olfactory receptor, family 4, subfamily E, member 2; K04257 olfactory receptor hsa:120793 OR56A4, OR11-49; olfactory receptor, family 56, subfamily A, member 4; K04257 olfactory receptor

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (4)

hsa04512 ECM-receptor interaction - Homo sapiens (human) (4)

hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4

hsa05010 Alzheimer's disease - Homo sapiens (human) (4)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6 hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 hsa:7384 UQCRC1, D3S3191, QCR1, UQCR1; ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2); K00414 ubiquinol-cytochrome c reductase core subunit 1 [EC:1.10.2.2]

hsa05214 Glioma - Homo sapiens (human) (4)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (4)

hsa:3635 INPP5D, MGC104855, MGC142140, MGC142142, SHIP, SHIP1, SIP-145, hp51CN; inositol polyphosphate-5-phosphatase, 145kDa; K03084 inositol polyphosphate-5-phosphatase hsa:3636 INPPL1, SHIP2; inositol polyphosphate phosphatase-like 1; K01106 inositol-1,4,5-trisphosphate 5-phosphatase [EC:3.1.3.56] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (4)

hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8 hsa:22824 HSPA4L, APG-1, Osp94; heat shock 70kDa protein 4-like; K09485 heat shock protein 110kDa hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8 hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (4)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18] hsa:4881 NPR1, ANPRA, ANPa, GUC2A, GUCY2A, NPRA; natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) (EC:4.6.1.2); K12323 atrial natriuretic peptide receptor A [EC:4.6.1.2]

hsa05210 Colorectal cancer - Homo sapiens (human) (3)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04310 Wnt signaling pathway - Homo sapiens (human) (3)

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (3)

hsa:3636 INPPL1, SHIP2; inositol polyphosphate phosphatase-like 1; K01106 inositol-1,4,5-trisphosphate 5-phosphatase [EC:3.1.3.56] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa05211 Renal cell carcinoma - Homo sapiens (human) (3)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04330 Notch signaling pathway - Homo sapiens (human) (3)

hsa:28514 DLL1, DELTA1, DL1, Delta; delta-like 1 (Drosophila); K06051 delta hsa:23220 DTX4, KIAA0937, MGC141899, RNF155; deltex homolog 4 (Drosophila); K06058 deltex hsa:4855 NOTCH4, FLJ16302, INT3, MGC74442, NOTCH3; notch 4; K02599 Notch

hsa05218 Melanoma - Homo sapiens (human) (3)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa00380 Tryptophan metabolism - Homo sapiens (human) (3)

hsa:26 ABP1, ABP, AOC1, DAO, DAO1, KAO; amiloride binding protein 1 (amine oxidase (copper-containing)) (EC:1.4.3.22); K11182 diamine oxidase [EC:1.4.3.22] hsa:169355 IDO2, INDOL1; indoleamine 2,3-dioxygenase 2 (EC:1.13.11.52); K00463 indoleamine 2,3-dioxygenase [EC:1.13.11.52] hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2]

hsa04520 Adherens junction - Homo sapiens (human) (3)

hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2] hsa:7454 WAS, IMD2, THC, THC1, WASP; Wiskott-Aldrich syndrome (eczema-thrombocytopenia); K05747 Wiskott-Aldrich syndrome protein

hsa05213 Endometrial cancer - Homo sapiens (human) (3)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa04120 Ubiquitin mediated proteolysis - Homo sapiens (human) (3)

hsa:672 BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PSCP, RNF53; breast cancer 1, early onset; K10605 breast cancer type 1 susceptibility protein hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] hsa:7189 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6; K03175 TNF receptor-associated factor 6

hsa04966 Collecting duct acid secretion - Homo sapiens (human) (3)

hsa:23545 ATP6V0A2, A2, ARCL, ATP6A2, ATP6N1D, J6B7, RTF, STV1, TJ6, TJ6M, TJ6S, VPH1, WSS; ATPase, H+ transporting, lysosomal V0 subunit a2 (EC:3.6.3.6); K02154 V-type H+-transporting ATPase subunit I [EC:3.6.3.14] hsa:527 ATP6V0C, ATP6C, ATP6L, ATPL, VATL, VPPC, Vma3; ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (EC:3.6.3.14); K02155 V-type H+-transporting ATPase 16kDa proteolipid subunit [EC:3.6.3.14] hsa:10312 TCIRG1, ATP6N1C, ATP6V0A3, Atp6i, OC-116 kDa, OC116, OPTB1, Stv1, TIRC7, Vph1, a3; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (EC:3.6.3.6); K02154 V-type H+-transporting ATPase subunit I [EC:3.6.3.14]

hsa04530 Tight junction - Homo sapiens (human) (3)

hsa:2037 EPB41L2, 4.1-G, DKFZp781D1972, DKFZp781H1755; erythrocyte membrane protein band 4.1-like 2; K06107 erythrocyte membrane protein band 4.1 hsa:23136 EPB41L3, 4.1B, DAL-1, DAL1, FLJ37633, KIAA0987; erythrocyte membrane protein band 4.1-like 3; K06107 erythrocyte membrane protein band 4.1 hsa:9223 MAGI1, AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3; membrane associated guanylate kinase, WW and PDZ domain containing 1; K05631 atrophin-1 interacting protein 3 (BAI1-associated protein 1)

hsa04972 Pancreatic secretion - Homo sapiens (human) (3)

hsa:683 BST1, CD157; bone marrow stromal cell antigen 1 (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:1179 CLCA1, CACC, CACC1, CLCRG1, CaCC-1, FLJ95147, GOB5, hCLCA1, hCaCC-1; chloride channel accessory 1; K05027 calcium-activated chloride channel family member 1

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (3)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00052 Galactose metabolism - Homo sapiens (human) (2)

hsa:2595 GANC, MGC138256; glucosidase, alpha; neutral C (EC:3.2.1.20); K12317 neutral alpha-glucosidase C [EC:3.2.1.20] hsa:2720 GLB1, EBP, ELNR1; galactosidase, beta 1 (EC:3.2.1.23); K12309 beta-galactosidase [EC:3.2.1.23]

hsa04150 mTOR signaling pathway - Homo sapiens (human) (2)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa04976 Bile secretion - Homo sapiens (human) (2)

hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor hsa:10998 SLC27A5, ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2; solute carrier family 27 (fatty acid transporter), member 5 (EC:6.2.1.7); K08748 solute carrier family 27 (fatty acid transporter), member 5 [EC:6.2.1.7]

hsa00340 Histidine metabolism - Homo sapiens (human) (2)

hsa:26 ABP1, ABP, AOC1, DAO, DAO1, KAO; amiloride binding protein 1 (amine oxidase (copper-containing)) (EC:1.4.3.22); K11182 diamine oxidase [EC:1.4.3.22] hsa:3067 HDC, MGC163399; histidine decarboxylase (EC:4.1.1.22); K01590 histidine decarboxylase [EC:4.1.1.22]

hsa00360 Phenylalanine metabolism - Homo sapiens (human) (2)

hsa:8639 AOC3, HPAO, SSAO, VAP-1, VAP1; amine oxidase, copper containing 3 (vascular adhesion protein 1) (EC:1.4.3.21); K00276 primary-amine oxidase [EC:1.4.3.21] hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2]

hsa04110 Cell cycle - Homo sapiens (human) (2)

hsa:1874 E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 E2F transcription factor 4/5 hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (2)

hsa:10554 AGPAT1, 1-AGPAT1, G15, LPAAT-alpha, LPAATA, MGC4007, MGC5423; 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (EC:2.3.1.51); K13509 lysophosphatidate acyltransferase [EC:2.3.1.51] hsa:79143 MBOAT7, BB1, FLJ41296, LENG4, LPIAT, LRC4, MBOA7, OACT7, hMBOA-7; membrane bound O-acyltransferase domain containing 7; K13516 lysophospholipid acyltransferase 7 [EC:2.3.1.-]

hsa00760 Nicotinate and nicotinamide metabolism - Homo sapiens (human) (2)

hsa:683 BST1, CD157; bone marrow stromal cell antigen 1 (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa04720 Long-term potentiation - Homo sapiens (human) (2)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa05219 Bladder cancer - Homo sapiens (human) (2)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]

hsa03450 Non-homologous end-joining - Homo sapiens (human) (2)

hsa:79840 NHEJ1, FLJ12610, XLF; nonhomologous end-joining factor 1; K10980 non-homologous end-joining factor 1 hsa:10111 RAD50, NBSLD, RAD502, hRad50; RAD50 homolog (S. cerevisiae); K10866 DNA repair protein RAD50 [EC:3.6.-.-]

hsa04914 Progesterone-mediated oocyte maturation - Homo sapiens (human) (2)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa04970 Salivary secretion - Homo sapiens (human) (2)

hsa:683 BST1, CD157; bone marrow stromal cell antigen 1 (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5] hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa00500 Starch and sucrose metabolism - Homo sapiens (human) (2)

hsa:2595 GANC, MGC138256; glucosidase, alpha; neutral C (EC:3.2.1.20); K12317 neutral alpha-glucosidase C [EC:3.2.1.20] hsa:2632 GBE1, GBE; glucan (1,4-alpha-), branching enzyme 1 (EC:2.4.1.18); K00700 1,4-alpha-glucan branching enzyme [EC:2.4.1.18]

hsa04730 Long-term depression - Homo sapiens (human) (2)

hsa:673 BRAF, B-RAF1, BRAF1, FLJ95109, MGC126806, MGC138284, RAFB1; v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] hsa:1394 CRHR1, CRF-R, CRF1, CRFR1, CRH-R1h, CRHR, CRHR1L, CRHR1f; corticotropin releasing hormone receptor 1; K04578 corticotropin releasing hormone receptor 1

hsa04971 Gastric acid secretion - Homo sapiens (human) (2)

hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18] hsa:389015 SLC9A4, DKFZp313B031, NHE4; solute carrier family 9 (sodium/hydrogen exchanger), member 4; K13961 solute carrier family 9 (sodium/hydrogen exchanger), member 4

hsa00350 Tyrosine metabolism - Homo sapiens (human) (2)

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (2)

hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C hsa:7384 UQCRC1, D3S3191, QCR1, UQCR1; ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2); K00414 ubiquinol-cytochrome c reductase core subunit 1 [EC:1.10.2.2]

hsa04320 Dorso-ventral axis formation - Homo sapiens (human) (2)

hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] hsa:4855 NOTCH4, FLJ16302, INT3, MGC74442, NOTCH3; notch 4; K02599 Notch

hsa04614 Renin-angiotensin system - Homo sapiens (human) (1)

hsa:5476 CTSA, GLB2, GSL, NGBE, PPCA, PPGB; cathepsin A (EC:3.4.16.5); K13289 cathepsin A (carboxypeptidase C) [EC:3.4.16.5]

hsa00240 Pyrimidine metabolism - Homo sapiens (human) (1)

hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]

hsa04540 Gap junction - Homo sapiens (human) (1)

hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]

hsa03030 DNA replication - Homo sapiens (human) (1)

hsa:79621 RNASEH2B, AGS2, DLEU8, FLJ11712; ribonuclease H2, subunit B; K10744 ribonuclease H2 subunit B

hsa03018 RNA degradation - Homo sapiens (human) (1)

hsa:3329 HSPD1, CPN60, GROEL, HLD4, HSP60, HSP65, HuCHA60, SPG13; heat shock 60kDa protein 1 (chaperonin); K04077 chaperonin GroEL

hsa04973 Carbohydrate digestion and absorption - Homo sapiens (human) (1)

hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa00280 Valine, leucine and isoleucine degradation - Homo sapiens (human) (1)

hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2]

hsa00330 Arginine and proline metabolism - Homo sapiens (human) (1)

hsa:26 ABP1, ABP, AOC1, DAO, DAO1, KAO; amiloride binding protein 1 (amine oxidase (copper-containing)) (EC:1.4.3.22); K11182 diamine oxidase [EC:1.4.3.22]

hsa05012 Parkinson's disease - Homo sapiens (human) (1)

hsa:7384 UQCRC1, D3S3191, QCR1, UQCR1; ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2); K00414 ubiquinol-cytochrome c reductase core subunit 1 [EC:1.10.2.2]

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (1)

hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00604 Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human) (1)

hsa:2720 GLB1, EBP, ELNR1; galactosidase, beta 1 (EC:3.2.1.23); K12309 beta-galactosidase [EC:3.2.1.23]

hsa00600 Sphingolipid metabolism - Homo sapiens (human) (1)

hsa:2720 GLB1, EBP, ELNR1; galactosidase, beta 1 (EC:3.2.1.23); K12309 beta-galactosidase [EC:3.2.1.23]

hsa00510 N-Glycan biosynthesis - Homo sapiens (human) (1)

hsa:79053 ALG8, CDG1H, MGC2840; asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae); K03849 alpha-1,3-glucosyltransferase [EC:2.4.1.-]

hsa00260 Glycine, serine and threonine metabolism - Homo sapiens (human) (1)

hsa:8639 AOC3, HPAO, SSAO, VAP-1, VAP1; amine oxidase, copper containing 3 (vascular adhesion protein 1) (EC:1.4.3.21); K00276 primary-amine oxidase [EC:1.4.3.21]

hsa00400 Phenylalanine, tyrosine and tryptophan biosynthesis - Homo sapiens (human) (1)

hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2]

hsa00270 Cysteine and methionine metabolism - Homo sapiens (human) (1)

hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2]

hsa05216 Thyroid cancer - Homo sapiens (human) (1)

hsa03020 RNA polymerase - Homo sapiens (human) (1)

hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]

hsa00250 Alanine, aspartate and glutamate metabolism - Homo sapiens (human) (1)

hsa:259307 IL4I1, FIG1; interleukin 4 induced 1 (EC:1.4.3.2); K03334 L-amino-acid oxidase [EC:1.4.3.2]

hsa04960 Aldosterone-regulated sodium reabsorption - Homo sapiens (human) (1)

hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa04130 SNARE interactions in vesicular transport - Homo sapiens (human) (1)

hsa:8674 VAMP4, VAMP-4, VAMP24; vesicle-associated membrane protein 4; K08513 vesicle-associated membrane protein 4

hsa05016 Huntington's disease - Homo sapiens (human) (1)

hsa:7384 UQCRC1, D3S3191, QCR1, UQCR1; ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2); K00414 ubiquinol-cytochrome c reductase core subunit 1 [EC:1.10.2.2]

hsa00910 Nitrogen metabolism - Homo sapiens (human) (1)

hsa:771 CA12, CAXII, FLJ20151, HsT18816; carbonic anhydrase XII (EC:4.2.1.1); K01672 carbonic anhydrase [EC:4.2.1.1]

hsa00601 Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human) (1)

hsa:10331 B3GNT3, B3GAL-T8, B3GN-T3, B3GNT-3, HP10328, TMEM3, beta3Gn-T3; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3; K07970 beta-1,3-N-acetylglucosaminyltransferase 3 [EC:2.4.1.-]

hsa03410 Base excision repair - Homo sapiens (human) (1)

hsa:8930 MBD4, MED1; methyl-CpG binding domain protein 4; K10801 methyl-CpG-binding domain protein 4 [EC:3.2.2.-]

hsa00511 Other glycan degradation - Homo sapiens (human) (1)

hsa:2720 GLB1, EBP, ELNR1; galactosidase, beta 1 (EC:3.2.1.23); K12309 beta-galactosidase [EC:3.2.1.23]

hsa02010 ABC transporters - Homo sapiens (human) (1)

hsa:10347 ABCA7, ABCA-SSN, ABCX, FLJ40025; ATP-binding cassette, sub-family A (ABC1), member 7; K05645 ATP-binding cassette, subfamily A (ABC1), member 7

hsa03320 PPAR signaling pathway - Homo sapiens (human) (1)

hsa:10998 SLC27A5, ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2; solute carrier family 27 (fatty acid transporter), member 5 (EC:6.2.1.7); K08748 solute carrier family 27 (fatty acid transporter), member 5 [EC:6.2.1.7]

hsa03050 Proteasome - Homo sapiens (human) (1)

hsa:5695 PSMB7, Z; proteasome (prosome, macropain) subunit, beta type, 7 (EC:3.4.25.1); K02739 20S proteasome subunit beta 2 [EC:3.4.25.1]

hsa00531 Glycosaminoglycan degradation - Homo sapiens (human) (1)

hsa:2720 GLB1, EBP, ELNR1; galactosidase, beta 1 (EC:3.2.1.23); K12309 beta-galactosidase [EC:3.2.1.23]

hsa00970 Aminoacyl-tRNA biosynthesis - Homo sapiens (human) (1)

hsa:3735 KARS, KARS2, KIAA0070, KRS; lysyl-tRNA synthetase (EC:6.1.1.6); K04567 lysyl-tRNA synthetase, class II [EC:6.1.1.6]

hsa00120 Primary bile acid biosynthesis - Homo sapiens (human) (1)

hsa03440 Homologous recombination - Homo sapiens (human) (1)

hsa:10111 RAD50, NBSLD, RAD502, hRad50; RAD50 homolog (S. cerevisiae); K10866 DNA repair protein RAD50 [EC:3.6.-.-]

hsa00410 beta-Alanine metabolism - Homo sapiens (human) (1)

hsa:8639 AOC3, HPAO, SSAO, VAP-1, VAP1; amine oxidase, copper containing 3 (vascular adhesion protein 1) (EC:1.4.3.21); K00276 primary-amine oxidase [EC:1.4.3.21]

hsa04115 p53 signaling pathway - Homo sapiens (human) (1)

hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6

hsa00561 Glycerolipid metabolism - Homo sapiens (human) (1)

Immune	Pathogens	Cancer	Diseases	Metabolism	Neuro-related	Signalling	Processes
Cytokine-cytokine receptor interaction (33)	Toxoplasmosis (23)	Pathways in cancer (11)	Autoimmune	Purine metabolism (5)	Neuroactive ligand-receptor interaction (10)	MAPK signaling pathway (17)	Osteoclast differentiation (27)
Phagosome (26)	Staphylococcus aureus infection (20)	Chronic myeloid leukemia (7)	Systemic lupus erythematosus (26)	Oxidative phosphorylation (5)	Axon guidance (10)	Apoptosis (11)	Cell adhesion molecules (CAMs) (24)
Natural killer cell mediated cytotoxicity (25)	Leishmaniasis (19)	Prostate cancer (6)	Type I diabetes mellitus (18)	Inositol phosphate metabolism (3)	Neurotrophin signaling pathway (10)	VEGF signaling pathway (6)	Endocytosis (16)
Hematopoietic cell lineage (21)	RIG-I-like receptor signaling pathway (14)	Pancreatic cancer (6)	Autoimmune thyroid disease (17)	Tryptophan metabolism (3)	ErbB signaling pathway (7) Myelin	Insulin signaling pathway (6)	Regulation of actin cytoskeleton (11)
Toll-like receptor signaling pathway (19+1)	Chagas disease (12)	Small cell lung cancer (5)	Allograft rejection (17)	Galactose metabolism (2)	Long-term potentiation (2) NMDA	Calcium signaling pathway (6)	Focal adhesion (9)
Jak-STAT signaling pathway (18)	Cytosolic DNA-sensing pathway (11)	Acute myeloid leukemia (4)	Graft-versus-host disease (17)	Histidine metabolism (2)	Long-term depression (2)	TGF-beta signaling pathway (5)	Spliceosome (6)
T cell receptor signaling pathway (17+2)	Epithelial cell signaling in Helicobacter pylori infection (9)	Non-small cell lung cancer (4)	Asthma (6)	Phenylalanine metabolism (2)		GnRH signaling pathway (4)	Olfactory transduction (4)
Chemokine signaling pathway (17)	Malaria (9)	Glioma (4)	Other Viral myocarditis (17)	Glycerophospholipid metabolism (2)		Phosphatidylinositol signaling system (4)	Extraxellular matrix receptor interaction (4)
Antigen processing and presentation (16)	Shigellosis (8)	Colorectal cancer (3)	Hepatitis C (15)	Nicotinate and nicotinamide metabolism (2)		Wnt signaling pathway (3)	Protein processing in endoplasmic reticulum (4)
Complement and coagulation cascades (14)	NOD-like receptor signaling pathway (8)	Renal cell carcinoma (3)	Hypertrophic cardiomyopathy (HCM) (6)	Starch and sucrose metabolism (2)		Notch signaling pathway (3)	Vascular smooth muscle contraction (4)
Intestinal immune network for IgA production (13)	Amoebiasis (8)	Melanoma (3)	Dilated cardiomyopathy (6)	Tyrosine metabolism (2)		mTOR signaling pathway (2)	Adherens junction (3)
B cell receptor signaling pathway (12)	Vibrio cholerae infection (5)	Endometrial cancer (3)	Prion diseases (5)			Cell cycle (2)	Ubiquitin mediated proteolysis (3)
Fc gamma R-mediated phagocytosis (9)	Bacterial invasion of epithelial cells (5)	Bladder cancer (2)	Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)				Collecting duct acid secretion (3)
Lysosome (8)	Pathogenic Escherichia coli infection (4)		Alzheimer's disease (4) Dementia				Tight junction (3)
Fc epsilon RI signaling pathway (6)			Type II diabetes mellitus (3)				Pancreatic secretion (3)
Leukocyte transendothelial migration (5)							Bile secretion (2)
Primary immunodeficiency (5)							Non-homologous end-joining (2)
Adipocytokine signaling pathway (5)							Progesterone-mediated oocyte maturation (2)
							Salivary secretion (2)
							Gastric acid secretion (2)
							Cardiac muscle contraction (2)
							Dorso-ventral axis formation (2)

These maps are generated by Kegg pathways from the Kanehisa laboratories, with thanks, and are subject to their copyright conditions: Genes are enhanced by

Pathway Search Result: Click on "show all objects" for figure legends. Yellow proteins contain HIV-1 vatches as do orange proteins which are also autoantigens in HIV-1 infection: The links in the summary table are Pubmed searches for HIV-1 + search term (e.g. toxoplasmosis , in progress)

Pathway Search Result